What one share of Biomea Fusion holds
We are a clinical‑stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases.
Biomea Fusion’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.47 |
|---|---|
| Cash and investments | $0.48 |
| Book value | $0.17 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$0.20 | — | — | — | −$0.00 |
| 2020 | — | −$0.51 | $0.00 | −$0.43 | — | $0.43 |
| 2021 | — | −$1.74 | $0.13 | −$1.62 | — | $6.14 |
| 2022 | — | −$2.80 | $0.04 | −$2.17 | — | $3.67 |
| 2023 | — | −$3.44 | $0.10 | −$2.93 | — | $4.72 |
| 2024 | — | −$3.83 | $0.01 | −$3.33 | — | $1.42 |
| 2025 | — | −$1.18 | — | — | — | $0.41 |
Common questions about Biomea Fusion
How much does one share of Biomea Fusion earn?
Over the last 12 months, Biomea Fusion lost $0.47 for each share.
Does Biomea Fusion pay a dividend?
Biomea Fusion didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Biomea Fusion’s book value per share?
Biomea Fusion’s book value is $0.17 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Biomea Fusion have?
Each share of Biomea Fusion has $0.48 of cash and investments, as of June 30, 2026.
Has Biomea Fusion bought back shares?
Biomea Fusion’s share count rose about 763% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.